
Stay Updated with the Latest Hancock Jaffe Laboratories HJLI News in Real Time
Find HJLI news now at Meyka AI. Stay informed with the latest Hancock Jaffe Laboratories stocks updates, including price news, market analysis, and expert insights.

SpaceX Stock Crashes Below IPO Price as Rinehart’s A$700m Gain Evaporates
SpaceX shares dropped below their US$135 IPO price, erasing US$903 billion in value. Australian billionaire Gina Rinehart’s estimated A$700m profit from the June listing has been wiped out.

Stock Market Alert: Will Nifty 50 Hold 24,000 as US-Iran Tensions Push Oil Up 4%?
Nifty 50 faces its next big test as oil prices spike again. Fresh US-Iran hostilities sent Brent crude to $78.67 a barrel on July 13, 2026. WTI crude climbed 3.4% to $73.87. The index closed the previous session at 24,206.90, up 1.02%. Traders are now closely watching whether the Nifty 50 holds above the 24,000…

Trump Fires All 3 Election Assistance Commission Members Before Midterms
Trump fired all three Election Assistance Commission members on July 9, disabling the federal agency that certifies voting systems and helps states run elections before the midterms.

Blue Jet Healthcare (NSE: BLUEJET) Surges 8.5% After Raising ₹800 Crore Through QIP at ₹506 Per Share
Blue Jet Healthcare shares jumped as much as 8.5% on July 10, 2026. The rally followed the company’s ₹800 crore fundraise through a Qualified Institutional Placement. Blue Jet Healthcare allotted 15,810,276 equity shares at ₹506 each, a discount to the floor price. The QIP window ran from July 6 to July 9, 2026, before the…

Dr Reddy’s (NSE: DRREDDY) Shares Tumble 7% After Semaglutide Launch Delay Due to API Quality Issue
Dr Reddy’s Laboratories shares tumbled nearly 7% on Thursday, July 9, 2026, on the NSE. The Hyderabad-based drugmaker disclosed a quality issue affecting its semaglutide active pharmaceutical ingredient. Certain batches were found out of specification, delaying commercial supplies indefinitely. Shares fell as much as 6.5% to an intraday low of ₹1,261.20 on the BSE. That…

Aurobindo Pharma (NSE: AUROPHARMA) Shares Slip Despite US FTC Approval for $250 Million Lannett Acquisition
Aurobindo Pharma shares edged lower on June 22, 2026, despite a significant regulatory win announced before market open. Aurobindo Pharma USA, a wholly-owned subsidiary, received approval from the US Federal Trade Commission to proceed with the $250 million acquisition of Lannett Company LLC on a cash-free, debt-free basis. It inclusive of normalized working capital, with…

Hancock Prospecting Cuts Jobs at Roy Hill Mine, June 18
Hancock Prospecting reduces Roy Hill workforce while developing Round Hill mine to sustain iron ore production above 63 million tonnes annually.

Hancock Iron Ore Cuts Hundreds of Jobs at Pilbara Mines, June 17
Hancock Iron Ore cuts jobs at Pilbara mines to extend mine life by 10 years while maintaining 63MTPA production rates.

Swiss Vegetable Market Faces New Regulatory Hurdles, June 16
Switzerland requires medical device registration and cosmetic compliance by June 2026, affecting vegetable market importers and producers.